Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Ramsay Health Care (RHC) vs. Competitors

83 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:RHCRamsay Health CareAUD 55.03AUD 12.64B40.0475.98%HoldUnlock the AU:RHC analyst price target with TipRanks PremiumAU:RHCUnlock the AU:RHC top-analyst price target with TipRanks Premium
AU:HLSHealius LimitedAUD 0.58AUD 417.55M-1.03-35.75%HoldUnlock the AU:HLS analyst price target with TipRanks PremiumAU:RHC vs AU:HLSUnlock the AU:HLS top-analyst price target with TipRanks Premium
AU:REGRegis Healthcare Ltd.AUD 5.13AUD 1.55B27.95-31.23%Moderate BuyUnlock the AU:REG analyst price target with TipRanks PremiumAU:RHC vs AU:REGUnlock the AU:REG top-analyst price target with TipRanks Premium
AU:SHLSonic Healthcare LimitedAUD 19.89AUD 9.83B16.14-6.44%HoldUnlock the AU:SHL analyst price target with TipRanks PremiumAU:RHC vs AU:SHLUnlock the AU:SHL top-analyst price target with TipRanks Premium
AU:IDXIntegral Diagnostics Ltd.AUD 1.67AUD 621.85M28.40-34.96%Moderate BuyUnlock the AU:IDX analyst price target with TipRanks PremiumAU:RHC vs AU:IDXUnlock the AU:IDX top-analyst price target with TipRanks Premium
AU:ACLAustralian Clinical Labs LtdAUD 3.35AUD 624.84M27.1424.54%HoldUnlock the AU:ACL analyst price target with TipRanks PremiumAU:RHC vs AU:ACLUnlock the AU:ACL top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:RHCRamsay Health Care55.0323.5774.92%
AU:HLSHealius Limited0.57-0.33-36.46%
AU:REGRegis Healthcare Ltd.5.13-2.07-28.78%
AU:SHLSonic Healthcare Limited19.89-0.06-0.29%
AU:IDXIntegral Diagnostics Ltd.1.67-0.74-30.68%
AU:ACLAustralian Clinical Labs Ltd3.350.8031.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts